O'Shaughnessy Asset Management, LLC Alaunos Therapeutics, Inc. Transaction History

O'Shaughnessy Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$1.09 - $1.89 $2,815 - $4,881	-2,583 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$2.2 - $3.71 $5,682 - $9,582	2,583 New	2,583 $8,000
Q1 2020 May 13, 2020	SELL	$1.9 - $4.98 $4,907 - $12,863	-2,583 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$3.95 - $5.35 $10,202 - $13,819	2,583 New	2,583 $12,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $458M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.